SAN FRANCISCO, CA, January 14, 2025 /24-7PressRelease/ -- Francis S. Kim has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Kim, a medical director at Kyverna Therapeutics since 2023, is a recognized expert in autoimmune diseases. In his current role, he leads two global clinical studies, one in the U.S. and one in Germany. Dr. Kim's responsibilities span from strategic decision-making to program discussions, internal and external collaborations, and overseeing execution of clinical trials.
Before his current position, Dr. Kim was the associate medical director of clinical development at Sonoma Biotherapeutics from 2022 to 2023. He also served as a clinical fellow in pediatric gastroenterology and hepatology at the University of California San Francisco (UCSF) Benioff Children's Hospitals between 2018 and 2022 and was a postdoctoral research fellow at UCSF from 2018 to 2021. Dr. Kim's foundational expertise took place at Tufts Medical Center (formerly the Floating Hospital for Children) as a resident physician in pediatrics between 2015 and 2018.
Dr. Kim's academic journey began at Harvard University, where he earned an A.B. in biology with a minor in Spanish. He then received his M.D. and M.A. at Boston University School of Medicine. His education was further enriched by board certification from the American Board of Pediatrics and certification in the design and interpretation of clinical trials from the Johns Hopkins Bloomberg School of Public Health. In 2022, Dr. Kim also completed an immersion course in drug discovery, development, and regulation from the UCSF's Stanford Center of Excellence in Regulatory Science and Innovation.
Across multiple companies and in partnership with leading academic clinicians and scientists, Dr. Kim is most proud of working with outstanding teams to understand the underlying biology of autoimmune diseases and translate that knowledge into innovative, safe, and effective therapies. Looking toward the future, Dr. Kim aims to continue advancing research in autoimmune diseases, hoping to create durable responses that address unmet needs and improve patients' quality of life. His goal is to shift the paradigm of treatment of autoimmune diseases and someday find cures for these diseases, a mission that motivates him every day.
In light of his success, Dr. Kim received the National Leadership Award from the American Medical Association Foundation. He was also fortunate to receive a T32 Grant from the National Institutes of Health. He attributes his accomplishments to seizing opportunities, receiving support from mentors, family, and friends, and his combined tenacity and resilience.
# # #
Contact Information
-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
USA
Telephone: 844-394-6946
Email: Email Us Here
Website: Visit Our Website